Dermatology Doctors in Little Silver, NJ Accepting Medicare

2 Dermatology doctors found. Showing 1 - 2

Dr. Christine Nevin Schafer, MD Dermatology Medicare: May Accept Medicare Assignments Practice Location: 180 White Rd Ste 103, Little Silver, NJ 07739 Phone: 732-842-5222

Dr. Kenneth A Grossman, M.D. Dermatology - Procedural Dermatology Medicare: May Accept Medicare Assignments Practice Location: 180 White Rd, Suite 103, Little Silver, NJ 07739 Phone: 732-842-5222    Fax: 732-741-6285

News Archive

First AngelMed Guardian cardiac monitor system implanted in patient at Jersey Shore

Today at Jersey Shore University Medical Center, 66-year-old heart attack survivor Charles Theodora from Ocean Township became the first NY/NJ Metropolitan resident to be implanted with the experimental AngelMed Guardian cardiac monitor and alert system device that could alert him if a heart attack is imminent.

State roundup: Minn. shutdown's health, economic impact significant

A variety of state services, such as background checks for employees and license renewals for health-care workers, are not available. … Some of the affects may seem small or transitory, such as modified or canceled vacation trips to state parks. But others are more serious, such as a senior citizen's move to a nursing home because the senior could not continue to live at home when home-care assistants could not get licenses during the shutdown or their backgrounds could not be checked out.

FDA takes initiative to adopt modern technologies for enhancing security of the drug supply chain

A key element of the U.S. Food and Drug Administration's mission is focused on helping to ensure that all products we regulate, including drugs available to consumers, are safe and of high quality. This means working to ensure greater accountability in our nation's drug supply chain.

Researchers examine efficacy of CT-P59 monoclonal antibody against SARS-CoV-2 Brazil variant

The therapeutic monoclonal antibody CT-P59 binds to the RBD of SARS-CoV-2, the site of these three major mutations, which may therefore reduce the potency of this antibody against the P.1 lineage. In a new study, the neutralizing potency of this monoclonal antibody towards both wildtype and P.1 SARS-CoV-2 is investigated. The researchers found that the ability to bind with the virus is impeded by the mutations, resulting in reduced potency in vitro.

Read more Medical News

› Verified 8 days ago